These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Complex formation between macromolecules and drugs. II. Binding of drug to the membrane in dialysis studies. Agren A Acta Pharm Suec; 1968 Feb; 5(1):37-44. PubMed ID: 5672092 [No Abstract] [Full Text] [Related]
25. Effect of ionic strength of buffer on the measurement of erythrocyte electrophoretic mobility. Ertan NZ; Rampling MW Med Sci Monit; 2003 Oct; 9(10):BR378-81. PubMed ID: 14523326 [TBL] [Abstract][Full Text] [Related]
26. Some remarks on the interaction of macromolecules with other molecules and ions. van Os GA Arzneimittelforschung; 1966 Nov; 16(11):1428-30. PubMed ID: 6015005 [No Abstract] [Full Text] [Related]
27. Meeting of the Physical Chemistry of Biological Macromolecules Study Group. Göttingen, 29 September 1983. Abstracts. Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1257-67. PubMed ID: 6629337 [No Abstract] [Full Text] [Related]
29. Size and shape of macromolecules. MELVILLE HW Nature; 1953 Jun; 171(4364):1087-9. PubMed ID: 13072496 [No Abstract] [Full Text] [Related]
30. Solubility of alkyl benzoates. II. Effect of dielectric constant on the solubility of substituted alkyl benzoates. Shihab F; Sprowls J; Nematollahi J J Pharm Sci; 1971 Jan; 60(1):56-9. PubMed ID: 5548242 [No Abstract] [Full Text] [Related]
31. Order of strength of ionic linkages in protein interactions. Lewin S Biochem J; 1969 Oct; 114(4):83P-84P. PubMed ID: 5343796 [No Abstract] [Full Text] [Related]
32. [New means of detecting individual large macromolecules]. Namiot VA Biofizika; 1979; 24(2):331-3. PubMed ID: 444618 [No Abstract] [Full Text] [Related]
33. Possible complex formation between macromolecules and certain pharmaceuticals. X. The interaction of some phenolic compounds with polyethylene glycols, polypropylene glycols, and polyvinylpyrrolidone. GUTTMAN D; HIGUCHI T J Am Pharm Assoc Am Pharm Assoc; 1956 Oct; 45(10):659-64. PubMed ID: 13366803 [No Abstract] [Full Text] [Related]
35. Proceedings: Polyvinylpyrrolidones and their influence on the dissolution rates of compounds of varying aqueous solubilities. Florence AT; Rahman A J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():55P. PubMed ID: 2730 [No Abstract] [Full Text] [Related]
36. Rheological and mucoadhesive characterization of poly(vinylpyrrolidone) hydrogels designed for nasal mucosal drug delivery. Alsarra IA; Hamed AY; Alanazi FK; Neau SH Arch Pharm Res; 2011 Apr; 34(4):573-82. PubMed ID: 21544722 [TBL] [Abstract][Full Text] [Related]
37. [Physico-chemical and biological peculiarities of thyrocalcitonin complexes with high molecular weight compounds]. Stekol'nikov LI; Katkovskiĭ SB; Tepelina OM; Konopatskaia VM; Abdukarimov A; Egorova TV Vopr Med Khim; 1969; 15(3):276-9. PubMed ID: 5805161 [No Abstract] [Full Text] [Related]
38. Kinetics of the polymerization of hemoglobin in high and low phosphate buffers. Adachi K; Asakura T Blood Cells; 1982; 8(2):213-24. PubMed ID: 6186320 [TBL] [Abstract][Full Text] [Related]
39. Examination of the flow rheological and textural properties of polymer gels composed of poly(methylvinylether-co-maleic anhydride) and poly(vinylpyrrolidone): rheological and mathematical interpretation of textural parameters. Jones DS; Lawlor MS; Woolfson AD J Pharm Sci; 2002 Sep; 91(9):2090-101. PubMed ID: 12210055 [TBL] [Abstract][Full Text] [Related]
40. [On the physicochemical properties of biological macromolecules]. Sadron C Pure Appl Chem; 1966; 12(1):63-83. PubMed ID: 5927155 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]